KDM4A and neuroblastoma: Treatment with microRNA inhibitors in neuroblastoma (SK-N-AS cells; Fig. 2, I and J) and lung cancer cells (H2591; Fig. 2, K and L) also increased KDM4A protein levels and promoted copy gain of 1q12h but not chromosome 8 centromere.